Concepedia

Author

Richard Adams

Cardiff UniversityORCID

Also Known As

Adams, R A, Adams, RA, Adams, Rachel, Adams, Richard, Adams, Richard A., Claire Blesing, Donald Pizer, G Davison, R A ADAMS, R A Adams

487

Publications

12.6K

Citations

53

H-Index

161

Concepts

All Affiliations

Cardiff UniversityVelindre Cancer CentreUniversity of OxfordUniversity College LondonCRUK/MRC Oxford Institute for Radiation Oncology
RA

About

Richard Adams is an author at Cardiff University specializing in medicine, cancer research, and oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Health Sciences

14

18

590

2

Engineering

4

4

185

3

Arts

1

1

14

4

Business

1

1

40

5

Education

1

1

12

Richard Adams

×

123

Publications

9.6K

Citations

47

H-Index

YearCitations

Addition of cetuximab to oxaliplatin-based first-line combination chemotherapy for treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial

Tim Maughan, Richard Adams, Christopher G. Smith,

The Lancet

2011

964

Prognosis of patients with peritoneal metastatic colorectal cancer given systemic therapy: an analysis of individual patient data from prospective randomised trials from the Analysis and Research in Cancers of the Digestive System (ARCAD) database

Jan Franko, Qian Shi, Jeffrey P. Meyers,

The Lancet Oncology

2016

628

Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Eugenia Abaleke, Mustafa Abbas, Sadia Abbasi,

The Lancet

2021

555

Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial

Obbina Abani, Ali Abbas, Fatima Abbas,

The Lancet

2021

516

Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Obbina Abani, Ali Abbas, Fatima Abbas,

The Lancet

2022

382

First-line selective internal radiotherapy plus chemotherapy versus chemotherapy alone in patients with liver metastases from colorectal cancer (FOXFIRE, SIRFLOX, and FOXFIRE-Global): a combined analysis of three multicentre, randomised, phase 3 trials

Harpreet Wasan, Peter Gibbs, Navesh Sharma,

The Lancet Oncology

2017

378

Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

Obbina Abani, Ali Abbas, Fatima Abbas,

The Lancet

2021

289

Intermittent versus continuous oxaliplatin and fluoropyrimidine combination chemotherapy for first-line treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial

Richard Adams, Angela Meade, Richard H. Wilson,

The Lancet Oncology

2011

262

Prespecified dose-response analysis for A Very Early Rehabilitation Trial (AVERT)

Julie Bernhardt, Leonid Churilov, Fiona Ellery,

Neurology

2016

210

Body Mass Index Is Prognostic in Metastatic Colorectal Cancer: Pooled Analysis of Patients From First-Line Clinical Trials in the ARCAD Database

Lindsay A. Renfro, Fotios Loupakis, Richard Adams,

Journal of Clinical Oncology

2015

176

Page 1